ProductCode:PM-HIV-NEF
Poolof15015mericpeptidesderivedfromNefproteindesignedtocoverthehighsequencediversityoftheHIvirusforTcellassays(e.g.ELISPOT).ProteinsequencesofallsubtypesofHIV-1/SIVcpzbasedontheHIVsequencedatabaseoftheLosAlamosNationalLabwereused.WedevelopedaproprietaryalgorithmtoobtainpeptidecombinationsprovidinganoptimalcoverageofproteinvariABIlity.
Amount:1vialcontaining15nmol(appr.25µg)perpeptide
Purity:>70%(HPLC-MS)
DeliveryFormat:Freezedriedinambertypeglassvial
Application(s):T-cellassays,Immunemonitoring,AntigenspecificT-cellstimulation,T-cellexpansion,Cellularimmuneresponse
Indication(s)/Topic(s):Infection,AIDS,Control
DeliveryTime:10-12days
PepMixes™HIVUltra
Thehumanimmunodeficiencyvirus(HIV)isthecausativeagentoftheacquiredimmunodeficiencysyndrome(AIDS),adisease,bywhichover25millionpeoplewerekilledinthepastthreedecades.ThemajordifficultywithHIVistheextremelyhighmutationrateoftheviralgenomeleADIngtoanenormousdiversityoftheHIVproteome,andallowingthevirustoescapethehumanimmuneresponse.Conventionalconsensusbasedpeptidepoolsaddressthisproblemonlyverypoorly.Therefore,whendesigningthenewHIV-1ENV,GAG,NEFandPOLUltraPepMix™PeptidePools,wefocusedprimarilyoncoverageofthetremendoussequencediversityofHIV.ProteinsequencesofallsubtypesofHIV-1/SIVcpzfromtheLosAlamosNationalLabwereconsidered.Wedevelopedaproprietaryalgorithmtoobtainpeptidecombinationsprovidingoptimalcoverageoftheproteinvariability.BroadcladecoverageprovidedbythesenewpeptidepoolsenablesstimulationandmonitoringofimmuneresponsesinHIVpatientsindependentofgeographicalorigin.
BenefitsofPepMix™
-EquivalentorbetterstimulationofCD4+andCD8+T-cellresponsescomparedtowholeproteinantigens
-SimultaneousdetectionofCD4+andCD8+responsesinasinglesample
-ImprovedresponsesinstoredbloodandPBMcellscomparedtowholeproteinantigens
-Morereliableascontrolthanphytohemagglutinin(PHA)andconcanavalinA(ConA)
-High-batch-to-batchreproducibility
-Reliablechemicalandbiochemicalqualitycontrolandqualityassuranceforpeptidesynthesisandpeptidepoolgeneration
-Prolongedshelfstabilitywhenstoredfreezedried
SelectedReferences
"InVitroStudiesoftheImpactofMaribavironCMV-SpecificCellularImmuneResponses"
Stacheletal.,JClinVirol. (2015)-PMID:26780109
"InductionOfBroad-basedImmunityandProtectiveEfficacybySelf-amplifyingmRNAVaccinesEncodingInfluenzaVirusHemagglutinin"
Brazzolietal.,JournalofVirology (2015)-PMID:26468547
"TargetingofNucleoproteintoChemokineReceptorsbyDNAVaccinationResultsinIncreasedCD8+-mediatedCrossProtectionAgainstInfluenza"
Baranowskaetal.,Vaccine(2015)-PMID:26387432
"CharacteristicsofImmuneMemory10-15yearsAfterPrimaryHepatitisBVaccination"
Hummeletal.,Vaccine(2015)-PMID:n.a.
"TCellsSpecificforDifferentLatentandLyticViralProteinsEfficientlyControlEpstein-BarrVirusTransformedBCells"
Nowakowskaetal.,Cytotherapy(2015)-PMID:26276009
"High-densityPrecultureofPBMCsRestoresDefectiveSensitivityofCirculatingCD8TCellstoVirus-andTumor-derivedAntigens"
Wegneretal.,Blood(2015)-PMID:26024876
"MetabolicRegulationofHepatitisBImmunopathologybyMyeloid-derivedSuppressorCells"
Pallettetal.,NatureMedicine(2015)-PMID:25962123
ApplicationNotes
"DevelopingMulti-HIVAntigenSpecificT-CellsasaComponentofaCureStrategy"
Lametal.(2015)Fulltext
"Peptide-stimulatedExpansionofVirus-specificTcellsForPreventativeTreatmentAfterAllogeneicStemCellTransplantation"
Garyetal.(2015)Fulltext
X
Testimonials
"Toestablishanovelroleformyeloidderivedsuppressorcells(Pallettetal,Nat.Med.2015)inchronicviralinfection,weutilisedthePepMixCEFPool(extended)aswellasacustomsynthesizedPepMixspanningthecoreregionofHBVgenotypeD.Whereas,theCEFpeptidepoolconsistsof32peptides,eachcorrespondingtoadefinedHLAclassI-restrictedT-cellepitopefromCytomegalo,Epstein-Barr,andInfluenzavirus,thelattercustomPepMixincluded15mericpeptidesoverlappingby10aminoacids.SpecificallythiscompositionenabledustomonitorboththeantiviralCD8+andCD4+TcellresponsesinchronicHBVinfectionandthenon-antigenspecificTcellsthatareknowntomediateimmunopathologyintheliver.OurentireexperiencewithJPT,fromordering/deliverytouseinthelabwasexcellent.Notonlywerethereagentsabletoperformreliablyandconsistentlyinvitrofrombatchtobatch,thecustomerandtechnicalsupportprovidedwascontinuallyavailableandefficientwhenneeded.JPTwillremainour"go-to"companyforpurchasingpeptides."
Dr.LauraJPallett,InfectionandImmunity,UniversityCollegeLondon,UK
Application | AntigenspecificT-cellstimulation Immunemonitoring T-cellassays T-cellexpansion |
ProteinName | Nefprotein(NEF) |
Organism | Humanimmunodeficiencyvirus(HIV) |
Indication/Topic | AIDS(HIV) |
Numberofpeptides | 150 |
Amount | 1vialcontaining15nmol(appr.25µg)perpeptide |
Specifications | Selectedimmunogenicpeptides(15mers) |
Documentation | Protocol,DatasheetandAnnotations |
Sequence | SeeDatasheetunderProduct Documentation |
SouthernBiotech/Goat Anti-Human Lambda-Alexa Fluor® 555/2070-32/1.0 mg
vectorlabs/Biotinylated Aleuria Aurantia Lectin (AAL)/B-1395/1 mg
vectorlabs/VECTASTAIN® Elite® ABC-HRP Kit (Peroxidase, Mouse IgG)/PK-6102/1 kit
vectorlabs/VECTASTAIN® Elite® ABC-HRP Kit (Peroxidase, Universal)/PK-6200/1 kit
vectorlabs/Unconjugated Musa Paradisiaca (Banana) Lectin (BanLec)/L-1410/5 mg
GiottoBiotech/Calmodulin N60D/5 mg/G02CLM60cn